Evolving Role of MRI in Assessment of Response of Hepatocellular Carcinoma Patients Post Trans-Arterial Chemoembolization: What Does the Physician Want to Know?

ROLE OF DYNAMIC CONTRAST-ENHANCED AND DIFFUSIONWEIGHTED MRI IN EVALUATION OF RESPONSE OF HEPATOCELLULAR CARCINOMA AFTER CHEMOEMBOLIZATION.

THE ROLE OF PET CT IN COMPARISON TO TRIPHASIC CT IN EARLY FOLLOW UP OF HEPATOCELLULAR CARCINOMA AFTER TRANSARTERIAL CHEMOEMOBLIZATION

Role of ADC Mapping in the Assessment of Therapeutic Response of Hepatocellular Carcinoma in Patients with Post-trans-catheter Arterial Chemoembolization

Role of triphasic CT in prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma patients

Role of Apparent Diffusion Coefficient (ADC) Mapping in Assessment of Therapeutic Response of Hepatocellular Carcinoma Post Trans-Catheter Arterial Chemoembolization

Role of diffusion weighted MRI in patients with hepatocellular carcinoma: prediction and assessment of response to trans-arterial chemoembolization

Role of Diffusion MRI & Dynamic Contrast-enhanced MRI in Assessment of Hepatocellular Carcinoma after Trans-arterial Chemoembolization

Role of Pet/Ct in Assessment of Post Therapeutic Hepatocellular Carcinoma

Role of MRI in Assessment of Hepatocellular Carcinoma (HCC) after TACE (Trans-arterial Chemoembolization) with Persistent High Alfa Fetoprotein (AFP)